Genetic analysis that assesses the risk of developing DM2
Diabetes mellitus (DM) is a group of metabolic disorders characterized by chronic hyperglycemia as a result of the poor insulin production or activity. If not diagnosed and treated, it can cause, in the long term, damage to the heart, blood vessels, eyes, kidneys and nerves which could result in premature death. The estimate is that about 50% of people with type 2 diabetes mellitus (DM2) remain undiagnosed and that by 2030 one in ten adults will be diagnosed with diabetes.
The risk of developing DM2 is determined by the combination of genetic factors, poor eating habits and a sedentary lifestyle. Several genes have already been linked to the disease, and changes in these genes increase the its risk of development.
Diabetesprevent is the first genetic analysis that assesses the risk of developing DM2. The exam consists of the simultaneous analysis of 16 genetic variants, evaluating the genetic risk of developing DM2, which is established based on a mathematical algorithm that integrates the statistical weight of each genetic variant, family history, and the anthropometric data of the patient.
The test can be taken at any time in the life and it is especially recommended in case of the following risk factors:
• Overweight and obesity (BMI ≥ 25 kg/m² in adults; BMI ≥ 85% in children).
• Elevated glucose levels (≥ 100 md/dL and/or glycated hemoglobin (A1C ≥ 5.7%).
• Family history of type II diabetes.
• History of gestational diabetes.
• High blood pressure.
• Guaranteed by the experience of the Synlab Group, the absolute European leader in laboratory diagnosis.
•Objective and detailed results report.
• Informed Consent
• Clinical Questionnaire
• No fasting is required for this exam